Business Club, May 7th. The reporter's recently held & ldquo; 2014 Children's Medicine Summit Forum & RDQUO;，2009，A survey of Beijing Children's Hospital shows，Among the 1067 kinds of medicines used in clinical practice，Foreign brands account for more than 70%，Only less than 30%is a variety produced by domestic enterprises。

 

But 2013，The re -survey data changes，The number of children's medicines independently produced stake online sports bettingin stake online sports bettingChina increases，rose to about 50%year -on -year in 2009。

 

The rise of independent research and development

 

In the past 10 years，Due to the small production of children's drug production batch、Batch more、The process is relatively complicated，Causes higher production costs。At the same time，Its development cycle is longer，Low profit，Many pharmaceutical companies are unwilling to produce children's medicine。Compared with adult medication，Scientific research funding for children's medicine is also very limited。

 

This situation has changed in recent years，A batch of professional children's medicine companies in my country quickly rise，& ldquo; Kangzhi & rdquo;、& ldquo; Good dolls & rdquo;、& ldquo; Dain & rdquo; domestic children's medicine brands represented by representatives began to emerge。Especially with the powerful tilt of the medical insurance reimbursement policy，​​The clinical status of domestic children's medicine began to increase。

 

Another，As the subjects of children's medicine research and development involve newborns、Baby、Children and other growth、Development stage，The complexity and risk of the clinical trials of children's drug itself are much higher than that of adult tests，So，my country has not been specialized in children's drug research stake sports betting appand My stake betting appdevelopment centers for a long time，Just research and development centers for adult drugs on behalf of research。2014，The first domestic medication research and development center in China was completed by Dain Pharmaceutical，A common disease in children、Study on the Drugs of Multi -disease and some rare disease treatment drugs。

 

Fast expansion of the market

 

Forecast according to the CFDA Southern Medical Economics Research Institute，In the future, the sales of children in my country will continue to maintain an average annual double -digit growth rate，It is expected that it will reach 66.893 billion yuan by 2015。

 

Deng Li, director of the Guangzhou Women's and Children's Medical Center, thinks，Although the hospital can be divided by dose，But parents may not be able to do it when they go to the pharmacy。Current，There are 7 pharmacists in Beijing Children's Hospital for special divisions，Generally comprehensive hospitals are difficult to do，Therefore, increase the drug dosage form，It may be a very good profit point for an enterprise。

 

Lack of special categories

 

Zhu Zonghan, Vice President of the Chinese Medical Association and President of Pediatrician Branch, believes，Although the proportion of clinical use of domestic children's drugs increases，But domestic products are still concentrated in stake betting appMy stake betting appcommon children's disease treatment drug markets，Some children's special unconventional disease therapy drugs，Still joint venture and foreign -funded enterprises occupy an advantage in competition。

 

A survey of Beijing Children's Hospital show，Although there are 54 clinical drugs in children's cardiology，But there are only local high -tech agents with special dosage forms for children，Registered and produced for Beijing Shuanghe Hi -Ke Natural Pharmaceutical Co., Ltd.，Other products are used by adults to dose。

 

In addition，And the company reflects that the current approval of children's medicine is too slow，The localization process of not conducive to children's medicine。At the same time，It is recommended to formulate relevant policies to give priority to this type of variety，to alleviate the problem of serious lack of current children's medicine。

 

Some experts suggest，Screening a group of children's medicine professional R & D and production enterprises nationwide，R & D of children's medicine、Registration review、Tendering、Pricing and medical insurance give strong funds and policy support，Formation of demonstration effects and scale effects in the country。At the same time，Use separate pricing policies for children's medicine，Cancel the prescription Stake Sports Bettingstake sports betting apprestrictions of the two regulations & rdquo;。